compounding — 17 things I got wrong before I got it right
Confession thread, sort of.
I went from 2.5mg to 1.0mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 8 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway.
So now I have early fullness I did not need and a data point I cannot interpret. Two lessons in one.
Posting it in the hope that somebody at week 89 reads it before doing the same thing.
best — the order this archive was captured in
shortage list status is 503A, check the actual list
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
the Poland situation is different from the US, different regulations
Strongly agree. API source transparency matters.
the shortage list is temporary, it ends and compounding becomes illegal again
shortage list status is 503A, check the actual list
Yes, exactly this, and it is the bit that took me 79 weeks to accept.
the 503A/503B distinction is load-bearing, do not blur it
Moved states and the compounding landscape changed completely. Different rules, different pharmacies, different costs.
the shortage list is temporary, it ends and compounding becomes illegal again
the shortage list is temporary, it ends and compounding becomes illegal again
Yes, exactly this, and it is the bit that took me 31 weeks to accept.
The confident tone is doing a lot of work that the evidence is not.
telehealth prescriber models exist, pricing differs by state
state board rules differ, say which state
Yeah, 503A and 503B are different regulatory animals.
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.
This is correct. The shortage list does expire and the rules change.
This is correct.
Disagree on that part. 99.2% and 99.0% on the same vial is normal.
This is correct.
Disagree on that part. 93.7% and 99.3% on the same vial is normal.
telehealth costs state board plus compounding markup, total varies
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.
no pharmacy referral codes, naming is fine, recruiting is not
That is net peptide content, not purity. Different number, different meaning.
503B compounding is different from 503A, different rules, different legality
state board rules differ, say which state
Three years on this site and the questions have not changed at all.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
shortage list status is 503B, check the actual list
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
- 1shortage list status is 503A, check the actual list9 comments in this branch · started by u/liver_enzyme_liz
- 2Three years on this site and the questions have not changed at all. Which is…8 comments in this branch · started by u/step_count_stan